Annelies Boonen

20.6k total citations · 2 hit papers
427 papers, 13.7k citations indexed

About

Annelies Boonen is a scholar working on Rheumatology, Economics and Econometrics and Immunology. According to data from OpenAlex, Annelies Boonen has authored 427 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 274 papers in Rheumatology, 78 papers in Economics and Econometrics and 74 papers in Immunology. Recurrent topics in Annelies Boonen's work include Rheumatoid Arthritis Research and Therapies (169 papers), Spondyloarthritis Studies and Treatments (162 papers) and Health Systems, Economic Evaluations, Quality of Life (73 papers). Annelies Boonen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (169 papers), Spondyloarthritis Studies and Treatments (162 papers) and Health Systems, Economic Evaluations, Quality of Life (73 papers). Annelies Boonen collaborates with scholars based in Netherlands, United States and United Kingdom. Annelies Boonen's co-authors include Désirée van der Heijde, Astrid van Tubergen, C. Stolwijk, Maarten Boers, Robert Landewé, Sjef van der Linden, Marloes van Onna, Johan L. Severens, Jürgen Braun and Arco C. Verhoeven and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Annelies Boonen

407 papers receiving 13.3k citations

Hit Papers

Randomised comparison of combined step-down prednisolone,... 1997 2026 2006 2016 1997 2022 250 500 750

Peers

Annelies Boonen
Kaleb Michaud United States
Michael M. Ward United States
John Kirwan United Kingdom
Leigh F. Callahan United States
Tanja Stamm Austria
Annelies Boonen
Citations per year, relative to Annelies Boonen Annelies Boonen (= 1×) peers Loreto Carmona

Countries citing papers authored by Annelies Boonen

Since Specialization
Citations

This map shows the geographic impact of Annelies Boonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelies Boonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelies Boonen more than expected).

Fields of papers citing papers by Annelies Boonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelies Boonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelies Boonen. The network helps show where Annelies Boonen may publish in the future.

Co-authorship network of co-authors of Annelies Boonen

This figure shows the co-authorship network connecting the top 25 collaborators of Annelies Boonen. A scholar is included among the top collaborators of Annelies Boonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelies Boonen. Annelies Boonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boonen, Annelies, et al.. (2025). The role of social determinants of health on disease outcomes in axial spondyloarthritis: A narrative review. Autoimmunity Reviews. 24(5). 103762–103762. 2 indexed citations
2.
Ramiro, Sofía, Elena Nikiphorou, Walter P. Maksymowych, et al.. (2024). Thresholds for unacceptable work state in radiographic axial spondyloarthritis of four presenteeism and two clinical outcome measurement instruments. Lara D. Veeken. 64(1). 358–366. 1 indexed citations
3.
Kiltz, Uta, Anna Moltó, Clementina López‐Medina, et al.. (2024). Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial. Seminars in Arthritis and Rheumatism. 69. 152542–152542.
5.
Webers, Casper, Annelies Boonen, Harald E. Vonkeman, & Astrid van Tubergen. (2023). Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry. The Journal of Rheumatology. 50(11). 1430–1438. 4 indexed citations
7.
Maas, L.M., Marloes van Onna, Dennis Cornelissen, et al.. (2023). Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture. Osteoporosis International. 35(1). 69–79. 5 indexed citations
8.
Pazmiño, Sofia, Anikó Lovik, Annelies Boonen, et al.. (2022). New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis. Lara D. Veeken. 62(1). 108–115. 8 indexed citations
9.
Boonen, Annelies, Joop P. van den Bergh, Sander M. J. van Kuijk, et al.. (2022). A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Journal of Medical Economics. 25(1). 829–839. 3 indexed citations
10.
Gwinnutt, James M., Maud Wieczorek, Javier Rodríguez‐Carrio, et al.. (2022). Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open. 8(2). e002167–e002167. 40 indexed citations
11.
Webers, Casper, Uta Kiltz, Jürgen Braun, Désirée van der Heijde, & Annelies Boonen. (2022). The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?. Lara D. Veeken. 62(6). 2139–2146. 2 indexed citations
12.
Boel, Anne, Victoria Navarro‐Compán, Annelies Boonen, et al.. (2021). Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. The Journal of Rheumatology. 48(12). 1810–1814. 5 indexed citations
13.
Taylor, Peter C., Désirée van der Heijde, Robert Landewé, et al.. (2021). A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis. The Journal of Rheumatology. 48(8). 1259–1267. 11 indexed citations
14.
Wit, Maarten de, Françis Guillemin, Sabine Grimm, et al.. (2020). Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?. RMD Open. 6(3). e001286–e001286. 6 indexed citations
15.
Dejaco, Christian, Alessia Alunno, J. W. J. Bijlsma, et al.. (2020). Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Annals of the Rheumatic Diseases. 80(4). 518–526. 51 indexed citations
16.
Nielsen, Sabrina Mai, Torkell Ellingsen, Beverley Shea, et al.. (2020). Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group. Annals of the Rheumatic Diseases. 79(10). 1269–1276. 4 indexed citations
17.
Putrik, Polina, Jany Rademakers, Mart van de Laar, et al.. (2019). SAT0558 IDENTIFYING HEATH LITERACY PROFILES OF RA AND SPA PATIENTS USING THE HEALTH LITERACY QUESTIONNAIRE. Annals of the Rheumatic Diseases. 78. 1371–1373.
18.
Vervloet, Marcia, et al.. (2019). Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Ramiro, Sofía, Polina Putrik, Yvonne van Eijk‐Hustings, et al.. (2018). The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.. PubMed. 36(2). 275–283. 1 indexed citations
20.
Webers, Casper, Sofía Ramiro, Robert Landewé, et al.. (2018). Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. RMD Open. 4(2). e000766–e000766. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026